Course Description

*This selection is for the Final Exam only. Access to the book, Exposure Therapy for Anxiety - Second Edition, is required to complete the exam. If you already have access to the book, click the "Buy" button above to continue. To order the e-Book from Guilford Press (which enables you to take the course immediately), click here. To order the paperback book from PRP, click here.

25 CE credits/hours, 200 questions

Target Audience

Psychologists | School Psychologists | Marriage & Family Therapists | Mental Health Counselors | Social Workers

Learning Level

Intermediate

Learning Objectives

  • Describe the history and evolution of using exposure therapy to treat clinical anxiety.
  • Explain the nature and development of clinical anxiety.
  • Identify the principles and goals of exposure therapy.
  • Explain the basics of developing a treatment plan for clinical anxiety.
  • Describe how to implement exposure therapy for animal-related fears.
  • Describe how to implement exposure therapy for environmental fears.
  • Describe how to implement exposure therapy for social fears.
  • Describe how to implement exposure therapy for contamination fears.
  • Describe how to implement exposure therapy for unwanted intrusive thoughts.
  • Identify bodily cues and health concerns involved in clinical anxiety.
  • Identify and describe exposure therapy for trauma-focused fear.
  • List blood-, injection-, and injury related stimuli.
  • Explain feelings of incompleteness, asymmetry, and “not-just-right” sensations.
  • Identify special considerations in the use of exposure techniques.
  • Apply exposure therapy in complex (co-occurring problems) cases.
  • Identify special considerations when using exposure therapy with children.
  • Explain the pros and cons of involving significant others in treating clinical anxiety with exposure therapy.
  • Identify the pros and cons of combining exposure therapy with medication.
  • Explain the methods for maintaining improvement after treatment.
  • Describe the possibilities available for using technology in exposure therapy for treating clinical anxiety.
  • Demonstrate how to combine Acceptance and Commitment Therapy (ACT) in conjunction with exposure therapy.
  • Identify the risk-benefit components of exposure therapy.

Sections

  1. 1

    • Statement of Understanding (downloadable/printable)
  2. 2

    • Final Exam Questions (downloadable/printable)

    • Final Exam
  3. 3

    • Evaluation Questionnaire

About the Authors

Jonathan S. Abramowitz, PhD, ABPP

Jonathan S. Abramowitz, PhD, ABPP, is Professor of Psychology and Neuroscience, Research Professor of Psychiatry, and Director of the Anxiety and Stress Disorders Clinic at the University of North Carolina at Chapel Hill. Dr. Abramowitz conducts research on anxiety disorders and has published over 250 articles, book chapters, and books. He serves as Editor of the Journal of Obsessive–Compulsive and Related Disorders and is on the editorial boards of several other scientific journals. He is past president of the Association for Behavioral and Cognitive Therapies and serves on the scientific and clinical advisory board of the International OCD Foundation. Dr. Abramowitz is a recipient of the Outstanding Contributions to Research Award from the Mayo Clinic Department of Psychiatry and Psychology and the David Shakow Early Career Award for Distinguished Scientific Contributions to Clinical Psychology from Division 12 of the American Psychological Association. His books include Getting Over OCD, Second Edition, and The Stress Less Workbook (for general readers).

Brett J. Deacon, PhD

Brett J. Deacon, PhD, is a clinical psychologist in private practice in Wollongong, Australia, and Conjoint Associate Professor at the University of New South Wales. He has published approximately 100 research articles and book chapters, served as Editor of The Behavior Therapist and Associate Editor of the Journal of Cognitive Psychotherapy, and is an editorial board member of numerous scientific journals. Dr. Deacon’s research examines the dissemination, optimal delivery, and acceptability of exposure therapy for anxiety. He is the recipient of numerous teaching, research, and student mentorship awards from the University of Wyoming, as well as the Golden Anniversary Alumni Award from Northern Illinois University College of Liberal Arts and Sciences. Dr. Deacon presents workshops around the world on exposure therapy.

Stephen P. H. Whiteside, PhD, ABPP

Stephen P. H. Whiteside, PhD, ABPP, is Professor of Psychology and Director of the Pediatric Anxiety Disorders Program at the Mayo Clinic in Rochester, Minnesota. His research focuses on improving access to evidence-based care for pediatric anxiety disorders and obsessive–compulsive disorder through the development of effective and efficient treatments facilitated by technology. Dr. Whiteside serves on the editorial board of the Journal of Anxiety Disorders and on the Education and Training Committee of the Minnesota Psychological Association. He has published over 60 scientific articles and is the codeveloper of the Mayo Clinic Anxiety Coach, a smartphone app that aids in the delivery of exposure.